Bedropuur

Bedropuur is a **standardized botanical cannabis product** developed by **Bedrocan Canada** and marketed under the Bedrocan portfolio as a pharmaceutical-grade medicinal cannabis chemovar. It is the commercial product name for the cultivar **Cannabis sativa L. Harmina**, an indica-dominant whole-plant cannabis preparation standardized to approximately **20% THC** and **less than 1% CBD**. Rather than acting as a single-molecule targeted therapy, Bedropuur delivers a reproducible phytochemical profile including cannabinoids and terpenes, with pharmacologic effects primarily attributed to THC-mediated modulation of the endocannabinoid system, especially cannabinoid receptors. The product was introduced in Canada for medical cannabis patients, later discontinued when Bedrocan exited the Canadian market, and has been described as being cultivated for possible reintroduction and for the European market.

Brand names

Bedropuur

Other names

Cannabis sativa L. HarminaBedropuur-Bedrocan Canada-standardized cannabis chemovar-botanical cannabis product